Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger


GERMANTOWN, Md., Oct.19, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Randal J. Kirk, Chairman and Chief Executive Officer, will participate in a CEO panel titled "Consolidation, Innovation, and the Road to Feeding 9 Billion by 2050" at the Borlaug Dialogue on October 19th at 3:15 pm CT.

Intrexon Corporation logo. (PRNewsFoto/Intrexon Corporation)

Intrexon is committed to utilizing engineered biology to address current and future challenges in feeding a growing population in a sustainable manner. Intrexon's Food Sector focuses on improving the quality of food and feed while enhancing our valuable ecosystems through innovative approaches such as:

The panel discussion will examine the technologies and policies needed to sustainably feed the world in 2050. A live webcast of the panel will be available at: http://www.worldfoodprize.org/live.

About The World Food Prize
The World Food Prize was founded in 1986 by Dr. Norman E. Borlaug, recipient of the 1970 Nobel Peace Prize. Since then, the World Food Prize has honored 45 outstanding individuals who have made vital contributions throughout the world. The World Food Prize annually hosts the Borlaug Dialogue international symposium and a variety of youth education programs to help further the discussion on cutting-edge global food security issues and inspire the next generation to end hunger.

The Norman E. Borlaug International Symposium, known informally as the "Borlaug Dialogue," brings together over 1,200 people from more than 65 countries to address cutting-edge issues related to global food security and nutrition. The three-day conference convenes a wide array of scientific experts, policy leaders, business executives and farmers and has been called "the premier conference in the world on global agriculture." Through the Borlaug Dialogue, the World Food Prize Foundation helps build alliances in the struggle against world hunger and malnutrition.

About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNAtm to create biologically-based products that improve the quality of life and the health of the planet.  The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.  We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.

Trademarks
Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.

Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information contact:

Investor Contact:

Christopher Basta

Vice President, Investor Relations

Tel: +1 (561) 410-7052

[email protected]

Corporate Contact:

Marie Rossi, Ph.D.

Director, Technical Communications

Tel: +1 (301) 556-9850

[email protected]

 

SOURCE Intrexon Corporation


These press releases may also interest you

at 16:05
Data I/O Corporation , the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced financial results for the first quarter ended March 31, 2024. First Quarter...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
Doximity, Inc. , the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a...



News published on and distributed by: